Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (131-140 of 456) with videos related to

Pageof 46
Sort By:
The Oncologist|April 5, 2007
The FDA in 2006: reasons for optimismBruce A Chabner, Thomas G Roberts
The Oncologist|December 17, 2013
Announcing a new section: Global health and cancerFelicia M Knaul, Bruce A Chabner
The Oncologist|July 19, 2011
FLT3 inhibition as therapy in acute myeloid leukemia: a record of trials and tribulationsAmir T Fathi, Bruce A Chabner
The New England Journal of Medicine|January 5, 2017
Limits to Precision Cancer MedicineJeffrey W Clark, Bruce A Chabner
The Journal of Clinical Investigation|August 1, 1973
Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissuesB A Chabner, R C Young
Lancet (London, England)|June 5, 2003
Using "rationally designed drugs" rationallyJim Brugarolas, Jeffrey W Clark, Bruce Chabner
The Oncologist|January 31, 2012
Editor's Note ...Clinical Trial Reports: A New SectionTito Fojo, Susan Bates, Bruce A Chabner
Croatian Medical Journal|May 30, 2002
Mechanisms of action and potential therapeutic uses of thalidomideHamza Mujagić, Bruce A Chabner, Zlata Mujagić
Cancer Treatment Reports|January 1, 1977
Metastatic mediastinal carcinoid treated with chemotherapyS Rosental, R W Balasa, B Chabner
JAMA|June 2, 1978
Adjuvant therapy of breast cancer: accomplishments and future courseB A Chabner, M Cohen, M Lippman
Pageof 46

Showing results (131-140 of 456) with videos related to

Sort By:
Pageof 46
The Oncologist|April 5, 2007
The FDA in 2006: reasons for optimismBruce A Chabner, Thomas G Roberts
The Oncologist|December 17, 2013
Announcing a new section: Global health and cancerFelicia M Knaul, Bruce A Chabner
The Oncologist|July 19, 2011
FLT3 inhibition as therapy in acute myeloid leukemia: a record of trials and tribulationsAmir T Fathi, Bruce A Chabner
The New England Journal of Medicine|January 5, 2017
Limits to Precision Cancer MedicineJeffrey W Clark, Bruce A Chabner
The Journal of Clinical Investigation|August 1, 1973
Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissuesB A Chabner, R C Young
Lancet (London, England)|June 5, 2003
Using "rationally designed drugs" rationallyJim Brugarolas, Jeffrey W Clark, Bruce Chabner
The Oncologist|January 31, 2012
Editor's Note ...Clinical Trial Reports: A New SectionTito Fojo, Susan Bates, Bruce A Chabner
Croatian Medical Journal|May 30, 2002
Mechanisms of action and potential therapeutic uses of thalidomideHamza Mujagić, Bruce A Chabner, Zlata Mujagić
Cancer Treatment Reports|January 1, 1977
Metastatic mediastinal carcinoid treated with chemotherapyS Rosental, R W Balasa, B Chabner
JAMA|June 2, 1978
Adjuvant therapy of breast cancer: accomplishments and future courseB A Chabner, M Cohen, M Lippman
Pageof 46